Androgen receptor expression and breast cancer survival in postmenopausal women. - Wikidata - awgldk - TriplyDB

Androgen receptor expression and breast cancer survival in postmenopausal women.

Androgen receptor expression and breast cancer survival in postmenopausal women.

http://www.wikidata.org/entity/Q34164902

about

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes Steroid hormones, steroid receptors, and breast cancer stem cells Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis Targeting the androgen receptor in prostate and breast cancer: several new agents in development A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Role of KCNMA1 in breast cancer.A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women Androgen Receptor as a Potential Target for Treatment of Breast Cancer.Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication.Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.Dietary lignan intake and androgen receptor expression in breast tumors.The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.CA1 contributes to microcalcification and tumourigenesis in breast cancer.Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression.

P2860

Q21195191-5A9A9DF8-4B89-42A5-9CE9-A1FD6467A952 Q26743510-AFC3CBE5-0F52-4BE4-9DA0-5B1AF0A81D81 Q26799113-FB3C53F1-1623-4360-B395-2B154CC0D3CD Q26823419-0916AFB5-2877-4FC0-BE02-4C3115360F7E Q27009424-A05173EA-73C4-49E4-8EAE-8809D063B626 Q28468359-56B627D6-E0FA-4A9B-9F86-84BBEA6FB297 Q30419961-49CE02EB-1C01-4227-B1E5-CA2A55041A19 Q31086046-1B89E376-B054-4B00-9EC5-37B000DE8F19 Q33618290-E50205AA-1403-457F-989A-67A19F5E816F Q33625672-6912BF60-984D-4E9D-AA43-A5DF3DAA9354 Q33632582-B88D8F22-A461-4D0C-8E46-FF7850C5A151 Q33728381-5DB31C1B-4226-42F8-A614-ECCDAB5E51B4 Q33739841-5A799E4A-FC42-4D65-840A-6DDA9E0FB64F Q33776271-D89DE3F4-459B-41A8-9B77-83C0E1B3EA3D Q33913872-890D4D44-9FCB-4A50-8700-D0B92BF39AE8 Q33932665-786C6F2A-1F50-4742-9A3A-7DA2670F6AF0 Q34043711-E7014E34-AFE8-4CA2-96B5-607ACCFECACE Q34092016-E3511BD1-D9E1-4756-B3D4-B9C9CC2E7C24 Q34228066-3E3F2EE5-FC96-43AE-BEC6-FA1FF545A3D1 Q34257434-6FAF0620-F5AA-4583-9F61-D4C362543EFF Q34292197-E731ABA7-2CDB-400B-AA02-C0563204D674 Q34309894-605B092B-15CC-42ED-9093-3A2D86727508 Q34323234-999F11AE-0CDD-4641-96A6-7854823E86C4 Q34475807-6280DFA6-D8F8-46E8-83F8-67A97DAE3C4D Q34499512-9D9C8E0F-75F8-410F-92EF-E2BF7C7F660A Q34512957-294D8F15-8B34-4576-A13B-01B44BDC4982 Q34550256-A37AB877-45D3-4642-B679-625488CE719E Q34573232-3F065FDB-BED9-4963-8AA3-C56DDE276F23 Q34995845-6565041C-A730-403A-92B9-A1CB831ACD49 Q35064269-1DE3EB8E-85CC-42D7-897F-FCD647C7F70C Q35176984-77FA2E6A-4AE4-4745-B0EC-D7F1F7A333C1 Q35546764-22CC18A2-E00A-49CA-80D6-95703F123868 Q35668330-2517A203-55F9-4864-B0DD-8B0D11A7718A Q35686249-34980289-E02D-4D0A-BFA6-0923F2F53C75 Q35713540-6E4C9926-24AF-49D7-865E-2204E2604960 Q35804012-7C9AC6D4-EC0E-4695-973D-701319011CA5 Q35892429-ED41154A-964F-4044-8AC6-374B0A7595F0 Q36014239-814E472E-2640-4349-9FAA-F3B43E505AC8 Q36113793-485936A2-A583-465F-802D-1FA275F732E4 Q36244715-F5AE74EB-8502-446B-BCBE-5B0C75D8AEFA

P2860

Androgen receptor expression and breast cancer survival in postmenopausal women.

http://www.wikidata.org/entity/Q34164902

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Androgen receptor expression and breast cancer survival in postmenopausal women.

@ast

Androgen receptor expression and breast cancer survival in postmenopausal women.

@en

Androgen receptor expression and breast cancer survival in postmenopausal women.

@nl

type

label

Androgen receptor expression and breast cancer survival in postmenopausal women.

@ast

Androgen receptor expression and breast cancer survival in postmenopausal women.

@en

Androgen receptor expression and breast cancer survival in postmenopausal women.

@nl

prefLabel

Androgen receptor expression and breast cancer survival in postmenopausal women.

@ast

Androgen receptor expression and breast cancer survival in postmenopausal women.

@en

Androgen receptor expression and breast cancer survival in postmenopausal women.

@nl

P1433

Q34164902-335F54AD-DC39-4EB4-B810-C1306365E96D

P1476

Q34164902-B66CC189-A1BE-4192-8F8B-91D6AA3D7D46

P2093

Q34164902-0C8F7682-8DC1-4584-98FC-3400246C0101

Q34164902-64856696-A0A1-421E-BB89-3E4B54E24D02

Q34164902-65FD6C62-5535-4049-9C37-156879E47086

Q34164902-8B44B67D-646A-4FD2-97BC-8B22C1565E30

Q34164902-C0F8D37A-9D56-4254-9F74-50249D0C78E8

Q34164902-DEA90229-B331-431D-BD4C-5D43FD059216

Q34164902-E876DAFD-F046-4D8A-BF20-7672CDBAAD9F

Q34164902-F92A4611-6EC5-44C4-8528-3423C3D66C09

P2860

Q34164902-001B9294-9DC8-4211-AA1C-78121EAAA102

Q34164902-0F8A818D-6EF8-4338-A8DD-FFC9017B933E

Q34164902-404A1722-A52B-4A63-A96E-4E55F76C7747

Q34164902-433B4ED4-035C-4084-A9C8-7D43ACA5AE92

Q34164902-488F78DF-92EE-48B3-9BB5-60DE58DF8CAE

Q34164902-5F0D11ED-DB5C-45C0-A693-87B89495DABB

Q34164902-664239D8-DE10-4B4D-8FE7-9E5DBCBA6471

Q34164902-76A384B9-6750-48C5-8587-9D6794E72E1E

Q34164902-8531AB87-24E5-4BE1-905D-BCDC5446259F

Q34164902-92FD7496-F484-40EA-A165-9BFDFBE23B95

P304

Q34164902-A2AFD04E-3393-470A-8A43-E66A6A5D70EE

P31

Q34164902-7B7610A6-FBF9-460D-9E42-DBA531AB6556

P356

Q34164902-09F63F35-9344-41DD-BD9F-172BAE60119A

P407

Q34164902-410E5A63-C8A1-40CE-8299-7539F9753A8C

P433

Q34164902-9B66BB78-21C2-4D40-A545-65EDE4575545

P478

Q34164902-2E15C8FA-C17E-4991-A9E2-0A61F14F0E9E

P50

Q34164902-76C3F8B9-B42A-4916-9E48-9D7A921820E4

Q34164902-AB9F3BF4-1904-4036-AC13-B396579F8E42

P577

Q34164902-4FCCA2E4-1FD3-4A95-8F3A-34FA72DA99E3

P698

Q34164902-896A6A8F-8D29-4C9F-8947-A3567F4CCB9E

P932

Q34164902-ED6ED8DF-24C3-4FBB-8928-BFB26903400F

P356

1078-0432.CCR-10-2021

P1433

Clinical Cancer Research

P1476

Androgen receptor expression and breast cancer survival in postmenopausal women.

@en

P2093

Jonathan D Marotti

http://www.w3.org/2001/XMLSchema#string

Kimberley Cole

http://www.w3.org/2001/XMLSchema#string

Laura C Collins

http://www.w3.org/2001/XMLSchema#string

Michelle D Holmes

http://www.w3.org/2001/XMLSchema#string

Rong Hu

http://www.w3.org/2001/XMLSchema#string

Rulla M Tamimi

http://www.w3.org/2001/XMLSchema#string

Shaheenah Dawood

http://www.w3.org/2001/XMLSchema#string

Stuart J Schnitt

http://www.w3.org/2001/XMLSchema#string

P2860

Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.

Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.

Identification of molecular apocrine breast tumours by microarray analysis.

Prognostic markers in triple-negative breast cancer.

P304

1867-1874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-2021

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Susan E Hankinson

P577

2011-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21325075

http://www.w3.org/2001/XMLSchema#string

P932

3076683

http://www.w3.org/2001/XMLSchema#string